SCHEMBL10972755

SCHEMBL10972755

Cc1cccc(Cl)c1NC(=O)NC1=NCCCN1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFB P00751 2/20 0.49
LMNA P02545 2/20 0.47
ADRA2A P08913 2/20 0.47
ADRA2B P18089 2/20 0.47
ADRA2C P18825 2/20 0.47
ADRA1D P25100 2/20 0.47
ADRA1A P35348 2/20 0.47
ADRA1B P35368 2/20 0.47
MEN1 O00255 1/20 0.47
SLC22A1 O15245 1/20 0.47
SLC22A3 O75751 1/20 0.47
HTR1A P08908 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
HRH2 P25021 1/20 0.47
CYP2C19 P33261 1/20 0.47
OPRK1 P41145 1/20 0.47
KMT2A Q03164 1/20 0.47
HIF1A Q16665 1/20 0.47
SLC47A1 Q96FL8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10972621 0.98 CFB (0.47) CFBLMNAADRA2AADRA2BADRA2C
Hydrochloric Acid SCHEMBL10972618 0.98 CFB (0.47) CFBLMNAADRA2AADRA2BADRA2C
SCHEMBL10976673 0.96 LMNA (0.46) CFBLMNAADRA2AADRA2BADRA2C
Hydrochloric Acid SCHEMBL10978311 0.95 LMNA (0.47) CFBLMNAADRA2AADRA2BADRA2C
SCHEMBL11084581 0.91 HTR1D (0.52) CFBLMNAADRA2AADRA2BADRA2C
SCHEMBL10972914 0.91 ADRA2A (0.52) CFBLMNAADRA2AADRA2BADRA2C
Hydrochloric Acid SCHEMBL10975432 0.90 ADRA2A (0.54) CFBLMNAADRA2AADRA2BADRA2C
Hydrochloric Acid SCHEMBL11081805 0.89 HTR1D (0.50) CFBLMNAADRA2AADRA2BADRA2C
SCHEMBL11178428 0.87 HTR1D (0.51) CFBLMNAADRA2AADRA2BADRA2C
SCHEMBL10975965 0.87 ADRA2A (0.51) CFBLMNAADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0042279-B1 N-ARYL-N'((1,4,5,6-TETRAHYDROPYRIMIDIN-2-YL) OR (4,5,6,7-TETRAHYDRO-1-H-1, 3-DIAZEPIN-2-YL)UREAS FOR INTESTINAL DISORDERS AND AS ANTIHYPERTENSIVES McNeilab, Inc. (US) 1985-11-13 EP claimed
US-4466966-A N-aryl-N'-(1,4,5,6-tetrahydropyrimidin-2-yl)ureas for intestinal disorders MCNEILAB, INC. (US) 1984-08-21 US claimed
EP-0042279-A2 N-aryl-N'((1,4,5,6-tetrahydropyrimidin-2-yl) or (4,5,6,7-tetrahydro-1-H-1, 3-diazepin-2-yl)ureas for intestinal disorders and as antihypertensives McNeilab, Inc. (US) 1981-12-23 EP claimed
US-4285948-A ADMINISTERING CARDIOTONIC AGENTS MCNEILAB, INC. (US) 1981-08-25 US claimed
EP-0042279-B1 N-ARYL-N'((1,4,5,6-TETRAHYDROPYRIMIDIN-2-YL) OR (4,5,6,7-TETRAHYDRO-1-H-1, 3-DIAZEPIN-2-YL)UREAS FOR INTESTINAL DISORDERS AND AS ANTIHYPERTENSIVES McNeilab, Inc. (US) 1985-11-13 EP disclosed
US-4466966-A N-aryl-N'-(1,4,5,6-tetrahydropyrimidin-2-yl)ureas for intestinal disorders MCNEILAB, INC. (US) 1984-08-21 US disclosed
EP-0042279-A2 N-aryl-N'((1,4,5,6-tetrahydropyrimidin-2-yl) or (4,5,6,7-tetrahydro-1-H-1, 3-diazepin-2-yl)ureas for intestinal disorders and as antihypertensives McNeilab, Inc. (US) 1981-12-23 EP disclosed
US-4285948-A ADMINISTERING CARDIOTONIC AGENTS MCNEILAB, INC. (US) 1981-08-25 US disclosed